Prexige (Lumiracoxib) - COX-2 Selective Inhibitor - Drug Information
Prexige (lumiracoxib) is a COX-2 selective inhibitor medication currently in development by Novartis. Drug information on the COX-2 selective inhibitor Prexige, generic drug name lumiracoxib. Prexige (lumiracoxib) has been approved in the United Kingdom. Prexige (lumiracoxib) is slated for approval in the United States in 2007.
10/03/2007: FDA Deems Arthritis Medicine Prexige "Not Approvable"
Prexige (lumiracoxib), a medicine being developed by Novartis as a once-daily treatment for arthritis patients with osteoarthritic pain, has not been approved by the U.S. Food and Drug Administration (FDA). On September 27, 2007, Novartis received a "not approvable" letter from the FDA.
Prexige (lumiracoxib), a medicine being developed by Novartis as a once-daily treatment for arthritis patients with osteoarthritic pain, has not been approved by the U.S. Food and Drug Administration (FDA). On September 27, 2007, Novartis received a "not approvable" letter from the FDA.
10/3/2007 - Prexige Withdrawn in Canada / USA Does Not Approve Prexige
Australia and Canada have withdrawn Prexige from the market citing liver complications. The U.S. has decided not to approve Prexige.
Australia and Canada have withdrawn Prexige from the market citing liver complications. The U.S. has decided not to approve Prexige.
What Are COX-2 Inhibitors?
A brief explanation and fast facts about the COX-2 inhibitors.
A brief explanation and fast facts about the COX-2 inhibitors.
Arthritis Drugs: What Are My Options?
Medications have long been considered "traditional" treatment. Since individual response to a specific medication can vary and because possible side effects are also a factor, finding the most effective medication or combination of medications can be a more difficult process than one would expect.
Medications have long been considered "traditional" treatment. Since individual response to a specific medication can vary and because possible side effects are also a factor, finding the most effective medication or combination of medications can be a more difficult process than one would expect.